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Abstract 
Trophoblast differentiation is a key event in human placental development. During extravillous trophoblast 
(EVT) differentiation, stem cells from the anchoring villi detach from their basement membrane and proliferate 
to form aggregates called trophoblast cell columns (TCCs). They subsequently invade the decidua and 
differentiate into interstitial and endovascular trophoblasts. The influence of the decidua on EVT differentiation 
is controversial. We therefore compared the pattern of trophoblast differentiation marker expression in viable 
intrauterine and tubal pregnancies, as decidual cell markers (prolactin [PRL] and insulin-like growth factor 
binding Protein-1 [IGFBP1]) were only expressed in endometrial implantation sites. Extravillous trophoblast 
differentiation in anchoring villi from uterine and ectopic pregnancies exhibited a comparable phenotypical 
switch: α6 integrin subunit, E-cadherin, EGF receptor, Ki 67 and connexin 40 were localized in the proximal part 
of the TCC, while α5βl and αl integrins, c-erb B2, hPL and HLA-G were expressed by invasive cytotrophoblasts. 
The cyclin-dependent kinase inhibitors pl6 and p57 were mainly detected in invasive cytotrophoblasts some 
distance from the columns. However, the TCC was markedly longer in tubal pregnancy than in intrauterine 
pregnancy. These findings suggest that the decidua is not necessary to trigger EVT invasion, but that it is likely 
to limit the extent of the TCC and to accelerate the onset of EVT migration. 
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INTRODUCTION 
Successful human placentation necessitates a series of events involving cellular and molecular interactions 
between specialized fetal and maternal cells. Two major morphologically and functionally distinct 
cytotrophoblast populations can be identified in human placenta. Villous cytotrophoblasts are polarized immotile 
cells that fuse to form the overlying syncytium in direct contact with maternal blood. Extravillous 
cytotrophoblast (EVT) cells derive from cytotrophoblasts (CTBs) that rest on a basement membrane surrounding 
the tips of anchoring villi. Extravillous trophoblasts proliferate and differentiate as they leave their basement 
membrane and form cellular aggregates (Le. trophoblast cell columns: TCC). When they become invasive, 
individual cytotrophoblasts invade the endometrium and, eventually, its arterial system (1). The human placenta 
is characterized by extensive invasion of EVTs into the maternal uterus, allowing trophoblasts to be in direct 
contact with maternal blood (hemochorial placentation) (2, 3). The EVTs switch from a proliferative to an 
invasive phenotype is governed by the sequentially regulated expression of a pleiad of genes (4-9). Extravillous 
trophoblast invasion proceeds mechanisms similar to those used by malignant cells to invade host tissues 
(10,11). 
In normal pregnancy, EVTs are in close contact with maternal decidual cells derived from the differentiation of 
endometrial stromal cells under the influence of progesterone. Decidualization is a feature unique to those 
species that exhibit invasive hemochorial placentation (12). The extent of decidualization in mammals is closely 
related to the degree of trophoblast invasiveness into the uterus (13). The most pronounced trophoblast invasion 
and decidual changes occur in humans. Decidualization is characterized (1) by the presence of swollen 
endometrial stromal cells (14), limited by a basement-membrane-like material (15, 16) (2), by the acquisition of 
specific endocrine activities, and (3) by the presence of numerous immune cells (17). 
Decidualization is generally regarded as an endometrial barrier that limits trophoblast invasion and protects the 
uterus from irreversible damage as a result of excessive hemochorial placentation (18-20). Others consider that 
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the decidua promotes trophoblast migration (12, 21). Several in vitro studies have attempted to evaluate the 
potential role of isolated decidual components in trophoblast activities (19, 21-23). However, in vitro 
experimental settings fail to mimic the complex in vivo situation. Ectopic pregnancy occurs in tissues that are 
classically considered to exhibit impaired or absent decidualization (2, 24-26). 
In this study, we first compared the expression of specific markers of decidualization (prolactin and IGFBP-1) in 
intrauterine and tubal pregnancies. We then examined the distribution of several markers of EVT proliferation, 
invasion and differentiation in normal and ectopic pregnancies in order to determine the possible contribution of 
the decidua to their expression by the EVTs. Despite the absence of decidualization markers in tubal pregnancy, 
the patterns of cadherins, integrins, connexins, epidermal growth factor receptor (EGF-R), c-erb-B2, human 
placental lactogen (hPL), human leukocyte antigen-G (HLA-G) and cyclin-dependant kinase inhibitors (pl6, p57) 
were identical to those of intrauterine pregnancies. However, the length of the TCC was considerably lower in 
intrauterine pregnancy. 
These data indicate that the acquisition of the EVT invasive phenotype occurs in the absence of decidua. They 
are however, consistent with a role of maternal decidual in limiting the size of the TCC and promoting the 
dissociation of cell aggregates and thereby the spreading of individual EVTs. 
MATERIALS AND METHODS 
Tissue sources 
Ectopic implantation sites were collected during 60 laparoscopic salpingectomies performed for tubal pregnancy. 
Age-matched first-trimester placentas were obtained by aspiration during legal elective abortion for non-medical 
reasons. In addition, full-thickness implantation sites in one hysterectomy specimen (10 weeks) were also 
studied. The protocol was approved by our local university Ethics Committee. The gestational age and viability 
of tubal pregnancies were determined by vaginal ultrasonography immediately before surgery (measure of the 
crown-rump length and fetal heart activity) and were also calculated from the time of embryo transfer during 
IVF procedures (Table 1). Specimens were frozen in liquid nitrogen and stored at -70°C until use, or fixed in 
neutral buffered 10% formalin before embedding in paraffin. 
Among the 60 pregnant tubes collected by salpingectomy, only six fulfilled the criteria of evolutive pregnancy. 
In these latter pregnancies, anchoring villi were observed with no evidence of necrosis, marked inflammatory 
infiltration or hemorrhage. In aborted ectopic pregnancies, typical anchoring villi could not be detected in all 
cases. 
The length of the trophoblast cell column was compared at tubal and intrauterine implantation sites. Using 
Olympus Micro-image 3.0.1 software (Omnilabo, Aartselaar, Belgium), we measured the distance separating the 
fetal mesenchyme core from the mesenchyme of the maternal decidua (for example, see → in Figs 1B3 and B4). 
Tubal pregnancies (n = 6) were compared with placental tissue obtained either by aspiration (n = 10) or by 
hysterectomy (one gravid specimen at 10 weeks of pregnancy). One hundred columns attached to the maternal 
site were measured. Statistical analysis was performed using the Mann-Whitney test. P-values less than 0.05 
were considered to denote significance. 
Morphological studies 
Antibodies 
The sources of the first-step antibodies are indicated in Table 2. Rhodamine-labeled rabbit antimouse and swine 
antirabbit antibodies were purchased from Dako (Glostrup, Denmark) (Table 2). 
Immunohistochemistry on frozen specimens 
Frozen sections (6 µm thick) were prepared using a Leica CM3050S cryostat and collected on 3-
aminopropyltriethoxysilan (Sigma, St Louis, MO) -coated glass microscope slides (Labonord, Belgium). 
Sections were fixed in acetone (-20°C) for 10min (for integrins α1, x5β1 and α6 and E-cadherin staining), in 4% 
paraformaldehyde for 20min (for HLA-G, Ki-67, cyclin-dependent kinase inhibitors pl6 and p57, EGF-R and c-
erb B2 staining) or in methanol at -20°C for 10min (for connexin 32, 40 and 43 staining). 
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After fixation, slides were washed three times in phosphate-buffered saline (PBS) for 5min. Non-specific 
binding sites were blocked by placing the slides in 10% bovine serum albumin (BSA, Sigma) for 30min. For 
EGF-R, c-erb B2 and connexins 32, 40 and 43, the blocking solution consisted of 2% BSA and 1% Triton X100 
in PBS. After three washes in PBS, the slides were incubated for 1 h with an appropriate dilution of the primary 
antibody (in 1% BSA) or overnight at 4°C (for connexins 32, 40 and 43). After five further washes, the second 
antibody conjugated to rhodamine was applied for 30 min and the slides were washed three times in PBS for 5 
min. After incubation with the different antibodies, nuclei were labeled with 4',6-diamidino-2-phenylindole 
(DAPI, 1µgmL-1) for 20 min, washed for 5 min in PBS and mounted with Aquapolymount anti-fading solution 
(Agar, UK). All incubations and washes were performed at room temperature. Appropriate controls were 
prepared with the same procedure but omitting the primary antibody or replacing the primary antibody with a 
non-specific IgG antibody at the same concentration. The controls were always negative. Samples were 




Table 1: Salpingectomy 
No. Implantation site Circumstances of diagnosis Gestational age (weeks) HCG (IU mL-1)
1 Ampulla Asymptomatic 11 58,000 
2 Ampulla Abdominal pain 8 9,640 
3 Ampulla Abdominal pain 8 13,100 
4 Ampulla IVF follow up 7 8,600 
5 Ampulla IVF follow up 6 7,000 
6 Ampulla IVF follow up 6 7,600 
*Cases excluded from detailed immunohistochemistry after histopathological evaluation. **Cases selected for precise analyses and 
immunohistochemistry. n = 60. 
 
Immunohistochemical staining of IGFBP-1, hPL and cytokeratin 7 
Paraffin sections (6 µm thick) were de-waxed in xylene and rehydrated in PBS. Endogenous peroxidase activity 
was quenched by incubation with 3% hydrogen peroxide in PBS for 10 min. Non-specific antibody binding was 
blocked by incubation for 30 min in blocking reagent containing 10% BSA in PBS. The primary antibodies 
(Table 2) were diluted in 1 % BSA and incubated with the sections for 1 h at room temperature. After washing, a 
peroxidase-conjugated swine anti-rabbit or rabbit antimouse antibody was applied for 30 min at room 
temperature. The slides were then incubated with a solution of diaminobenzidine and 0.03% hydrogen peroxide, 
then washed in running tap-water and counterstained with hematoxylin. Sections were mounted in Eukitt 
(Labonord, Belgium), examined and photographed under an Olympus IX50 microscope. Controls were prepared 
as described above. 
 Prolactin RT-PCR 
Tubal implantation sites (n = 6) containing floating and anchoring villi and the tubal wall were identified 
histologically on hematoxylin-stained frozen slides. Ten 10-µm thick frozen sections were prepared in a Leica 
CM3050S cryostat and placed in lysis buffer (Rneasy Mini Kit, Qiagen, GmbH, Hilden, Germany) for RNA 
extraction. Using the same procedure, RNA was also extracted from normal implantation sites of five 
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intrauterine first-trimester pregnancies and from six uterine decidua samples from the patients who had tubal 
pregnancies (n = 6). Prolactin gene expression (PRL) was also examined in endometrial tissue from the 
proliferative phase (negative controls, n = 10) and the late luteal phase (positive controls, n = 10). 
For RNA purification, samples were lyzed, then homogenized and processed as recommended by the 
manufacturer. 
 
Fig. 1: (A) First-trimester uterine and fallopian tube pregnancies. (B) First-trimester anchoring villous with 
extravillous trophoblasts (EVTs) forming the cell column at the fetal-maternal interface in uterine pregnancy 
(UP) and viable tubal pregnancy (TP) (B1 and B2: hematoxylin and eosin staining). Scale bar = 100µm. 
Immunoperoxidase labeling with anticytokeratin 7 antibody stained all trophoblast populations, including the villous trophoblast and EVTs 
(B3 and B4). Long → denote the direction of EVT migration. VM = villous mesenchyme; EVT = extravillous trophoblast of the cell column. 
Scale bar = 100 µm. 
 
 
Prolactin gene expression mRNA and 28S rRNA were measured in aliquots of total RNA (10 ng) by RT-PCR. 
RT-PCR was carried out using the GeneAmp Thermostable rTth reverse transcriptase RNA PCR kit (Perkin 
Elmer, Branchburg NJ) and two pairs of primers (Eurogentec, Liège, Belgium). The sequence of the sense 
primer for PRL was δ'-GGTGACCCTTCGAGACCTGTT-S' and that of the antisense primer                                    
5'-GGAAGAAGTGTGGCAGCTGTT-3'. The sequence of the sense primer for 28S rRNA was                                  
5'-GTTCACCCAC-TAATAGGGAACGTGA-3', and that of the antisense primer                                                      
5'-GATTCTGACTTAGAGGCGTTCAGT-3'. Reverse transcription was performed at 70° C for 15min, followed 
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by 2min of incubation at 95° C to denature the RNA-DNA heteroduplexes. Amplification started at 94°C for 15 
s, 30 s at 60° and 15 s at 72°C for 35 cycles for PRL (for 28S rRNA the annealing temperature was 20 s at 68° C 
and extension was 10 s at 72° C for 19 cycles) and terminated by 2 min at 72° C The RT-PCR products were 
resolved on 10% acrylamide gels and analyzed using a Fluor-S Multilmager (Bio-Rad, Hercules, CA) after 
staining with Gelstar dye (FMC Bioproducts, Rockland, ME). The expected sizes of the PRL mRNA and 28S 
rRNA were 150 bp and 212 bp, respectively. RT-PCR was performed three times on each sample. 
 
Table 2: Antibodies used for immunohistochemistry 
Antigens mAbs Species Isotype Dilution Suppliers 
Cytokeratin 07 OV-TL 12/30 Mouse IgG1 1:200 Dako 
Vimentin V9 Mouse IgG1 1/200 Dako 
hPL A0137 Rabbit - 1:300 Dako 
hPRL - Rabbit - 1:200 Dr Parlow-NIDDK 
hPRL A0569 Rabbit - 1.200 Dako 
hPRL NCL-PRO Mouse lgG3 1:200 NovoCastra 
IGFBP-1 6303 Mouse - 1:100 Medix Biochemica 
α6 subunit SP2/0 Mouse lgG2b 1:50 Immunotech (Cappel) 
α5β1 P1D6 Mouse lgG3 1:50 Dako 
 subunit TS2/7 Mouse IgG1 1:50 T Cell Diagnostic 
E-Cadherin SHE 78-7 Mouse lgG2 1/100 Zymed 
EGF-R - Mouse IgG1 1:100 Genzyme 
c-erbB2 9G6 Mouse IgG1 1:10 Calbiocem 
Connexin 40 - Rabbit - 1:50 Dr D. Gros, Marseille 
Connexin 32 - Mouse IgG1 1:100 Zymed 
Connexin 43 - Mouse IgG1 1:100 Transduction Laboratories
p16 P16 (F-12) Mouse IgG1 1/150 Santa Cruz Biotechnology
p57  Mouse IgG1 1/150 Santa Cruz Biotechnology
Ki-67 MIB-1 Mouse IgG1 1:50 Immunotech 
HLA-G W6/32 Mouse lgG2a 1/100 Leinco Technologies 
 
RESULTS 
Most ectopic pregnancies occur in the ampulla. Figure 1A schematically illustrates uterine and fallopian 
implantation sites. Figure 1B shows the typical structure of an anchoring villous in utero (Fig. 1B1) and in a 
fallopian tube (Fig. 1B2). The fetal mesenchymal core is surrounded by a layer of cytotrophoblast covered by the 
syncytium, and the EVTs form cellular aggregates called TCCs. Using an anticytokeratin 7 antibody, which 
stains all trophoblast populations, trophoblastic cells were distinguished from non-epithelial maternal cells of the 
uterine decidua (Fig. 1B3) or the fallopian tube (Fig. 1B4). In pregnant tubes, trophoblast cells that had migrated 
into the fallopian tube tended to have the morphology of cohesive rounded cells (Figs 1B2,4 and 7B, D, F). 
Absence of decidual cells in tubal implantation sites 
To detect decidual cells in tubal pregnancies, we studied PRL expression in tubal implantation sites by means of 
RT-PCR. As shown in Fig. 2, PRL transcripts were observed in the secretory endometrium in normal 
pregnancies, and in the intrauterine decidua in tubal pregnancies. In contrast, no expression was detected in the 
tubal implantation sites or proliferative endometrium. As previously reported (27, 28), significant cross-
reactivity of commercial anti-PRL antibodies with hPL precluded their use for immunohistochemical studies of 
placental tissue. IGFBP-1, another marker of decidual cells, was not expressed in the tubal implantation sites 
(Fig. 3C), but was clearly expressed in the intrauterine decidua of both normal (Fig. 3A) and tubal pregnancies 
(Fig. 3B). In the serial sections, vimentin staining (Fig. 3D) identified maternal mesenchymal cells, and 
cytokeratin or hPL staining confirmed the presence of invasive EVTs in tubal implantation sites (Fig. 3E and F). 
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Pattern of trophoblast differentiation markers in uterine and tubal pregnancies (Table 3) 
Integrin expression pattern 
Figure 4A shows the intense and polarized localization of the α6 integrin subunit at the basal pole of villous 
trophoblasts. The α6 staining was no longer polarized and gradually weakened as trophoblast distance from the 
anchoring site increased, disappearing in the deepest layers. No differences in α6 integrin subunit distribution 
were found between the uterine and tubal pregnancies. 
Uterine and tubal implantation sites displayed a similar α5β1 integrin distribution, which was exactly opposite to 
the α6 integrin subunit distribution, with positive staining of distal trophoblasts only (Fig. 4B). 
Positive staining for the α1 integrin subunit was observed in the mesenchymal core of the fetal villi in the tubal 
and intrauterine pregnancies (Fig.4C). At the implantation site of the intrauterine and ectopic pregnancies, the αl 
integrin subunit was absent from the proximal part of the cell column. This αl integrin subunit was again 
expressed by invasive trophoblast cells in the distal part of the column (Fig.4C). The α1-expressing EVTs in 
distal columns were distinguished from maternal cells by cytokeratin 7 staining of serial sections (data not 
shown). This pattern is identical to that observed in intrauterine pregnancies, as previously reported (8, 29). 
Fig. 2: Analysis of prolactin (PRL) and 28S mRNA RT-PCR products amplified from proliferative endometrium 
(PE, m =10), secretory endometrium (SE, m = 10) and uterine decidua from patients with tubal pregnancy 
(decidua, m = 6), uterine pregnancy (UP, m = 5) and tubal pregnancy (TP, m = 6). (A) Representative electrophoresis 
of prolactin (PRL) and 28S RT-PCR products showing the absence of PRL transcripts in proliferative endometrium and tubal pregnancy 
(TP). (B) PRL mRNA levels estimated from the density of the electrophoresis band. Values are mean ± SEM and represent the PRL to 28S 
band density ratio. Prolactin transcripts, used as a marker of decidualization, are restricted to late secretory endometrium and to the 
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Fig. 3: Immunoperoxidase staining for IGFBP-1, used as a marker of decidual differentiation. 
(A)   IGFBP-1 detection in decidualized endometrial stromal cells (→) of an intrauterine pregnancy (UP). 
(B)  Endometrial stromal cells (→) in a representative case of tubal pregnancy (TP) also express IGFBP-1. Staining for IGFBP-1 (C), 
vimentin (D), CK7 (E) and hPL (F) was performed on serial sections from a representative tubal implantation site. Arrowheads show 
invasive extravillous trophoblasts (EVTs) reacting with anti-CK7 (E) and antihPL (F) antibodies. Vimentin-positive cells correspond to 
stromal cells and vascular cells. Scale bar = 50 µm. 
 
 
E-cadherin and connexins 
In both uterine and tubal implantation sites, E-cadherin was detected in villous trophoblasts and in proximal 
EVTs, but was minimally expressed in distal EVTs (Fig. 5A). 
In both uterine and tubal implantation sites, Cx-40 staining was prominent in the proximal cell column, where 
cells were still in close contact with each other (Fig. 5B). Cx-40 was absent from distal and dispersed EVTs. Cx-
43 was restricted to the villous trophoblasts of endometrial and tubal pregnancies. The pattern of expression was 
again identical in the two situations (data not shown). 
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Other differentiation markers 
We then examined the tubal implantation sites for the distribution of several other proteins that are differentially 
expressed during EVT differentiation in intrauterine placentation. 
Cell cycle markers 
Anti-Ki 67 (Fig. 6A), an S-phase marker, stained the villous cyto-trophoblast and EVTs closely apposed to fetal 
mesenchyme in the proximal part of the TCC, as reported in normal pregnancy (7, 30). 
The cyclin-dependent kinase inhibitors pl6 and p57, which are markers of the G1 phase and G1-S phase of the 
cell cycle, respectively, were immunolocalized in the tubal pregnancies. Trophoblasts in cell columns were non-
reactive, but deeply invasive EVTs were positive for these markers (data not shown). This pattern of expression 
is consistent with other recent data (7). 
EGF-R and c-erb B2 
In normal pregnancy, EGF-R is reported to be expressed in proximal but not in distal EVTs, whereas c-erb B2 
displays the opposite pattern (31, 32). As shown in Fig.6B and C, EGF-R and c-erb B2 staining of the tubal 
pregnancy's EVTs showed reciprocal expression patterns similar to the intrauterine situation. 
HLA-G 
Only distal EVTs of the cell column reacted with anti-HLA-G antibody in the tubal implantation sites, with a 
pattern similar to that previously reported in uterine pregnancy (Fig. 6D) (33, 34). 
 
Table 3: First-trimester staining patterns of trophoblastic differentiation markers 
 Syncytium Cytotrophoblasts 
   Villous Extra-villous 
     Proliferative Invasive 
 TP UP TP UP TP UP TP UP 
Cytokeratin 7 + + + + + + + + 
Integrins 
α6 0 0 + + + + 0 0 
α5β1 0 0 0 0 0 0 + + 
α1 0 0 0 0 0 0 + + 
Cell-cell adhesion molecules 
E-Cadherin 0 0 + + + + 0 0 
Connexin 40 0 0 0 0 + + 0 0 
Connexin 43 0 0 + + 0 0 0 0 
Proto-oncogenes 
EGF-R + + + + 0 0 0 0 
c-erbB2 + + 0 0 0 0 + + 
Cell cycle proteins 
Ki-67 0 0 + + + + 0 0 
p57 0 0 0 0 0 0 + + 
pl6 0 0 0 0 0 0 + + 
Others 
HLA-G 0 0 0 0 0 0 + + 
hPL + + 0 0 0 0 + + 
+: tubal pregnancy (TP) and uterine pregnancy (UP) mean, respectively, positivity in implantation sites from TPs and UPs. 0: negative 
staining. 
Published in: Tissue Antigens (2003), vol. 62, iss. 2, pp. 104-116 
Status: Postprint (Author’s version) 
 
HPL 
In the tubal and uterine pregnancies, hPL staining predominated in the syncytiotrophoblast and EVTs in the 
distal column (Figs. 7A and B). Only a small percentage of EVT cells (cytokeratin-positive), (Fig. 7C and D) 
were positive for hPL. This pattern is identical to that described in uterine pregnancies by Kurman (35) and in 
ectopic pregnancies described by Earl and Chemnitz (36, 37). 
Morphometry 
We compared the length of EVT columns by measuring the distance separating the fetal mesenchymal core from 
the maternal mesenchyme. Mesenchymal cells were identified by vimentin staining (Fig. 7E and F). The 
trophoblastic nature of the cell column was confirmed by cytokeratin 7 reactivity (Fig. 7C and D). Mean length 
of the EVT columns was significantly higher in the tubal pregnancies (n = 100, 540 µm ± 33) than in the 
intrauterine pregnancies (n = 100, 170 µm ± 8.6, P< 0.0001) (Fig.7G). In the tubal pregnancies, the distal zone 
of the TCC was particularly enlarged (Fig. 7B, D and F). This zone was minimal or lacking in the intrauterine 
pregnancies (Fig.7A, C, E). 
DISCUSSION 
The decidual epithelial, together with stromal and inflammatory cells, secretes various molecules (prolactin, 
IGFBP-1, IL-1, IL-6, TNF-α, EGF, LIF, TGF-β, etc.) and matrix metalloproteinases or inhibitors (TIMPs) that 
regulate trophoblast differentiation, proliferation and invasion (11, 17, 21, 38). 
Transfer of mouse blastocysts to ectopic non-decidualized soft tissues resulted in more extensive trophoblast 
invasion than observed in the uterus (39-41). When transplanted subcutaneously, trophoblasts also invaded blood 
vessels, leading to the formation of hemorrhagic nodules (18). The trophoblast overgrowth that occurred in the 
absence of decidua in IL-11R-knockout mice also supports the hypothesis that the decidua plays a role in 
restricting trophoblast invasion (42). These data therefore suggest that decidual tissue acts as a barrier to 
excessive trophoblast invasion. 
In vitro studies also support decidual control of placentation, through feto-maternal paracrine interactions (22, 
43, 44). For example, IGF-1 stimulates (while TGF-β inhibits) cytotrophoblast detachment from the distal 
column and migration in streams across the maternal extracellular matrix (45, 46). 
To further examine the role of the decidua in the control of trophoblast invasion, we compared the distribution of 
trophoblast differentiation markers in tubal and intrauterine pregnancies. 
As it was still controversial whether or not tubal implantation sites undergo decidual differentiation (2, 24, 26, 
47-51), we examined the distribution of two key specific markers of decidual cells (PRL and IGFBP-1) with RT-
PCR or immunohistochemistry (Figs 2 and 3). In contrast to the uterine sites, the tubal implantation sites did not 
contain PRL transcripts or IGFBP-1-positive cells, strongly supporting the absence of decidua formation. This is 
in agreement with our previous observation (25) of large numbers of uterine natural killer (uNK) cells in uterine 
decidua and their absence in tubal implantation sites. 
In the proximal part of the anchoring villi, EVTs adhere to the fetal basement membrane through α6β4 integrin 
and actively proliferate, as revealed by Ki-67 staining (30, 52). These cohesive cells are linked by intercellular 
adhesion and junction molecules (E-cadherin and connexin 40) (53-55). They express the specific EGF-R 
receptor (31, 32). When differentiating towards an invasive phenotype, EVTs stop proliferating (Ki-67, pl6, 
p57), lose intercellular adhesion molecules (cadherin-E), switch to different junctional proteins (connexins 32, 40 
and 43) and integrins (α6β4, α5β1, α1β1), and express distinct surface receptors (EGF-R, c-erb-B2, HLA-G) and 
specific hormones (hPL). This process is known as 'the phenotype switch' (6, 8, 9). Our data shows that all these 
markers had precisely the same expression pattern regardless of the implantation site (Table 3). This clearly 
indicates that the EVT phenotype switch is fully maintained in tubal pregnancies and does not require a 
differentiated decidua. The switch thus appears to be essentially insensitive to the maternal environment, as 
previously suggested by in vitro studies: expiant culture of placental villi or isolated EVTs on a type I collagen 
matrix or Matrigel is sufficient to induce this phenotype switch (5, 56, 57). 
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Fig. 4: Expression of α6, α5β1 and α1 integrins in uterine (UP) and tubal (TP) anchoring villi and cell columns 
at the fetal-maternal interface in first-trimester pregnancies. Dual immunostaining for integrins (red): α6 subunit (panel A), 
α5β1 (panel B) and αl subunit (panel C); and for nuclear staining with DAPI (blue) in uterine (UP) and tubal pregnancy (TP). Single 
stainings (integrin or DAPI) are shown with a merge of the two images. α6 labeling is restricted to villous cytotrophoblast cells and to the 
proximal EVT of the trophoblastic cell column (TCC). α5 is present in the distal EVT of the TCC. α1 is located in the villous mesenchyme 
and in the distal EVT of the TCC. No differences in the distribution of αl, α5βl, and α6 integrins were seen between uterine (UP) and tubal 
pregnancies (TP). Arrowheads show the first layers of the EVT and → the distal part of the column. VM = villous mesenchyme and EVT = 
extravillous trophoblast of the cell column. Scale bar = 100 µm. 
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Fig. 5: Expression of E-cadherin and connexin 40 in first-trimester uterine and tubal anchoring villi and cell 
columns at the fetal-maternal interface. Dual immunostaining for E-cadherin in panel A (red) and for nuclear staining with DAPI 
(blue). Single staining (integrin or dapi) are shown together with merged images. E-cadherin is expressed by villous cytotrophoblasts and the 
first layers (Arrowheads) of the proximal part of the TCC in both uterine (UP) and tubal pregnancies (TP). Immunostaining for connexin 40 
(panel B) in UP and TP, and nuclear staining with DAPI (blue). Connexin 40 is expressed by the EVT of the TCC. Arrowheads show the first 
layers of the EVT and → the distal part of the column. VM = villous mesenchyme, EVT = extravillous trophoblast of the cell column. Scale 
bar = 100 µm. 
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Fig. 6: Immunostaining for Ki-67, EGF-R, HLA-G and c-erb B2 in tubal pregnancy (TP). Arrowheads show the first 
layers of the extravillous trophoblast (EVT) and → the distal part of the column. VM = villous mesenchyme, EVT = extravillous trophoblast 
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Fig. 7: (A,B) hPL immunostaining identifies the syncytium and invasive extravillous trophoblasts (EVTs) in tubal 
(TPs) and uterine (UPs) pregnancies. (C,D) Cytokeratin 7 staining identifies all villous and extravillous trophoblasts and permits 
precise measurement of the length of the column. (E,F) Vimentin staining identifies mesenchymal cells in fetal villi and in the tubal wall. 
Scale bar = 200 µm. (G) Comparison of the length of trophoblast cell columns (n = 100) in UPs and TPs (P< 0.0001). 
 
 
Interestingly, the TCC was considerably longer in the tubal than uterine pregnancies (Fig. 7G). Despite the 
down-regulation of E-cadherin and the α6β4 integrin and the up-regulation of the α5βl and αlβl integrins in the 
distal part of the column, the EVTs remained cohesive in the absence of decidua (Figs. 7B and C). This points to 
a need for a maternal signal, presumably of decidual origin, to generate a motile phenotype. Identification of 
factors that control trophoblast invasion, paracrine regulation of invasion effectors (eg. inhibition of MMPs by 
TIMPs) or extra-cellular matrix components remains a major challenge for reproductive biologists. 
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Taken together, our data indicate that while the EVT switch is not triggered by decidua, decidual cells are likely 
to support EVT dispersion into the maternal endometrium. 
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